Market revenue in 2024 | USD 22.2 million |
Market revenue in 2030 | USD 43.5 million |
Growth rate | 12.1% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 72.07% in 2024. Horizon Databook has segmented the India deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
India is anticipated to be the most prominent deep brain stimulation devices market owing to the increase in prevalence of brain-associated disorders such as PD and epilepsy. Moreover, the geriatric population is more susceptible to neurological disorders such as PD, brain stroke, OCD, and epilepsy.
Thus, the incidence of such disorders is expected to increase in the next 10 years, which is likely to create growth opportunities in deep brain stimulation devices market over the forecast period. In addition, growing need for quality healthcare and lack of matching delivery mechanisms are not only challenges in this field but also growth opportunities in the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account